TegoScience Inc. (KOSDAQ:191420)
14,200
0.00 (0.00%)
At close: Feb 19, 2026
TegoScience Market Cap
TegoScience has a market cap or net worth of 114.89 billion as of February 20, 2026. Its market cap has decreased by -13.03% in one year.
Market Cap
114.89B
Enterprise Value
77.72B
Revenue
6.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,200.00
Market Cap Chart
Since November 6, 2014, TegoScience's market cap has increased from 110.54B to 114.89B, an increase of 3.94%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 114.89B | -11.96% |
| Dec 30, 2025 | 130.51B | 30.50% |
| Dec 30, 2024 | 100.00B | -14.80% |
| Dec 28, 2023 | 117.38B | 20.16% |
| Dec 29, 2022 | 97.68B | -43.87% |
| Dec 30, 2021 | 174.03B | -29.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 151.05B |
| NovMetaPharma | 145.02B |
| BIO-FD&C | 136.78B |
| IMGT Co.,Ltd. | 105.07B |
| CTCBIO | 101.61B |
| KoBioLabs | 95.64B |
| Progen | 95.48B |
| Cell Biotech | 95.34B |